UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
83.79 +0.98 (+1.18%) GOLD FUTURES
2,344.50 +6.10 (+0.26%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,809.80 +604.33 (+1.18%)
Amedisys, Inc. (AMED)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 91.05 |
| Open | 90.90 |
| Bid | 83.04 x 200 |
| Ask | 97.97 x 200 |
| Day's range | 90.33 - 91.61 |
| 52-week range | 73.10 - 96.44 |
| Volume | |
| Avg. volume | 279,574 |
| Market cap | 2.978B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Zacks
Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
Amedisys (AMED) delivered earnings and revenue surprises of 1.98% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Amedisys (AMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.